| Price | 4.54p on 07-04-2026 at 18:30:08 |
|---|---|
| Change | -0.06p -1.3% |
| Buy | 5.01p |
| Sell | 4.40p |
| Last Trade: | Sell 51.00 at 4.54p |
| Day's Volume: | 2,178,416 |
| Last Close: | 4.54p |
| Open: | 5.20p |
| ISIN: | GB0033711010 |
| Day's Range | 4.48p - 5.20p |
| 52wk Range: | 1.40p - 19.00p |
| Market Capitalisation: | £28.33m |
| VWAP: | 4.634961p |
| Shares in Issue: | 623.91m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Immupharma (IMM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 51 | 4.54p | Uncrossing Trade |
16:35:08 - 07-Apr-26 |
| Sell* | 100,000 | 4.48p | Automatic Execution |
16:26:59 - 07-Apr-26 |
| Sell* | 50,000 | 4.55p | Automatic Execution |
16:26:57 - 07-Apr-26 |
| Sell* | 844 | 4.555p | Automatic Execution |
16:26:57 - 07-Apr-26 |
| Sell* | 15,129 | 4.555p | Automatic Execution |
16:26:57 - 07-Apr-26 |
| Sell* | 67,304 | 4.555p | Automatic Execution |
16:26:57 - 07-Apr-26 |
| Sell* | 240,000 | 4.54057p | Ordinary |
16:26:47 - 07-Apr-26 |
| Sell* | 18,264 | 4.555p | Automatic Execution |
16:25:36 - 07-Apr-26 |
| Buy* | 782 | 5.11p | SI Trade |
16:22:49 - 07-Apr-26 |
| Buy* | 22 | 5.11p | SI Trade |
16:22:49 - 07-Apr-26 |
Immupharma (IMM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 7th Apr 2026 11:45 am | RNS | Result of General Meeting and TVR |
| 27th Mar 2026 7:00 am | RNS | P140 Program Update |
| 23rd Mar 2026 7:00 am | RNS | Result of WRAP Retail Offer and TVR |
| 19th Mar 2026 9:00 am | RNS | Publication of Circular |
| 18th Mar 2026 7:00 am | RNS-R | ‘Investor Meet Company’ presentation on 20 March |
| 17th Mar 2026 7:01 am | RNS | WRAP Retail Offer for up to £1.5 million |
| 17th Mar 2026 7:01 am | RNS | WRAP Retail Offer for up to £1.5 million |
| 17th Mar 2026 7:00 am | RNS | P140 Update; Fundraise, Related Party Transaction |
| 17th Mar 2026 7:00 am | RNS | P140 Update; Fundraise, Related Party Transaction |
| 6th Jan 2026 4:11 pm | RNS | Holding(s) in Company |
